Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research

FHS
May 1, 2024
2:19 pm

Zentiva announces voluntary public purchase offer for APONTIS PHARMA – Investment Agreement signed – Biotech Investments

EQS-News: Zentiva AG / Key word(s): Mergers & Acquisitions Zentiva announces voluntary public purchase offer for APONTIS PHARMA – Investment Agreement signed 16.10.2024 / 11:55

October 17, 2024

Aneuploidy could function as a therapeutic target for cancer

Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming

July 6, 2023

Cybin Reports Second Quarter Financial Results and Recent Business Highlights | Psychedelic Invest

–Announced unprecedented positive Phase 2 interim data for CYB003, its proprietary deuterated psilocybin analog, in major depressive disorder – – Announced closing of a unit

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.